Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
78 hedge funds and large institutions have $60.8M invested in Histogen Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 13 closing their positions.
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
29% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 17
12% more call options, than puts
Call options by funds: $677K | Put options by funds: $606K
11% more funds holding
Funds holding: 70 → 78 (+8)
6% more capital invested
Capital invested by funds: $57.5M → $60.8M (+$3.34M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.66M |
| 2 |
Morgan Stanley
New York
|
+$1.38M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.19M |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$766K |
| 5 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
+$734K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.71M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$720K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$288K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$230K |
| 5 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$156K |
HSTO Hedge Fund Activity: Q3 2017 in Review
78 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2017, worth a combined $60.8M — up 5.8% from $57.5M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new HSTO positions and 13 closed out — a net gain of 9 holders — while 22 added to existing stakes and 17 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $1.66M. The largest seller was Bogle Investment Management, cutting an estimated $1.71M.
- 78 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2017, up from 70 in Q2 2017.
- Funds reported $60.8M of Histogen Inc. Common Stock stock for Q3 2017, up 5.8% quarter-over-quarter.
- 22 funds opened new Histogen Inc. Common Stock positions in Q3 2017 and 13 closed out, a net change of +9 holders.
- The largest Histogen Inc. Common Stock buyer in Q3 2017 was AQR Capital Management, an estimated $1.66M added.
- The largest Histogen Inc. Common Stock seller in Q3 2017 was Bogle Investment Management, an estimated $1.71M sold.
Based on aggregated 13F filings for Q3 2017.